Literature DB >> 11602689

Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1.

F Islinger1, M Gekle, S H Wright.   

Abstract

The kidney is the primary target organ in which inorganic mercury (Hg2+) accumulates and expresses its toxic effects. The chelating agent 2,3-dimercapto-1-propanesulfonic acid (DMPS) can rapidly reduce the renal burden of mercury and increase the urinary excretion of mercury. However, the cellular and molecular basis of its efficacy is still unknown. A number of previous studies implicated the "classical organic anion secretory pathway" in the secretion of DMPS and its chelation products. In this study we used the human ortholog of the organic anion transporter (hOAT1) expressed in the Xenopus oocyte expression system to study the interaction of DMPS and its mercury chelates with hOAT1. [3H]PAH was used to show the transport activity of hOAT1 (Km = 3.9 +/-1.3 microM). Uptake of [3H]para-aminohippuric acid (PAH) was inhibited by reduced DMPS (K(i) = 22.4 +/- 8.4 microM). We also investigated the interaction of oxidized DMPS with hOAT1 because it has been shown that at least 80% of DMPS in the blood is oxidized within 30 min. Oxidized DMPS also inhibited uptake of [3H]PAH (K(i) = 66 +/-13.6 microM). In contrast, we found no interaction of the DMPS-Hg chelate with hOAT1. To determine whether DMPS and oxidized DMPS are transported by hOAT1 we examined the effect of inwardly directed gradients these two compounds on efflux of [3H]PAH from HeLa cells transiently transfected with hOAT1. Gradients of both DMPS and oxidized DMPS significantly trans-stimulated efflux of [3H]PAH. These data suggest that hOAT1 can transport DMPS and oxidized DMPS, whereas the DMPS-Hg chelate has no significant affinity for the transporter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602689

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Authors:  Rudolfs K Zalups; Christy C Bridges
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  Organic anion transporter 3 (OAT3) and renal transport of the metal chelator 2,3-dimercapto-1-propanesulfonic acid (DMPS).

Authors:  Matthias Rödiger; Xiaohong Zhang; Bernhard Ugele; Nikolaus Gersdorff; Stephen H Wright; Gerhard Burckhardt; Andrew Bahn
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 5.  The aging kidney and the nephrotoxic effects of mercury.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-02-07       Impact factor: 6.393

6.  Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  J Pharmacol Exp Ther       Date:  2007-10-16       Impact factor: 4.030

7.  MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.

Authors:  Christy C Bridges; Lucy Joshee; Rudolfs K Zalups
Journal:  Toxicol Sci       Date:  2008-05-28       Impact factor: 4.849

Review 8.  Mechanisms involved in the transport of mercuric ions in target tissues.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  Arch Toxicol       Date:  2016-07-15       Impact factor: 5.153

Review 9.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 10.  Chronic Kidney Disease and Exposure to Nephrotoxic Metals.

Authors:  Sarah E Orr; Christy C Bridges
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.